Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro

This publication has 14 references indexed in Scilit:

• New acquisitions in the development of anti-HIV agents
  Antiviral Research, 1989
• Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
  The Journal of Experimental Medicine, 1989
• Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro
  Biochemical and Biophysical Research Communications, 1989
• Cytokines Alter Production of HIV-1 from Primary Mononuclear Phagocytes
  Science, 1988
• Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
  Journal of Virological Methods, 1988
• Cytokine-Induced Expression of HIV-1 in a Chronically Infected Promonocyte Cell Line
  Science, 1987
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity
  Biochemical Pharmacology, 1986
• Long-Term Seropositivity for Human T-Lymphotropic Virus Type III in Homosexual Men Without the Acquired Immunodeficiency Syndrome: Development of Immunologic and Clinical Abnormalities
  Annals of Internal Medicine, 1986
• Infection of human T-lymphotropic virus type-1 (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): Chronological studies of early events
  Virology, 1985